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Hypoxia inducible factor 1a (HIF-1a)
Neuronal development
Conditional knock out mouseAutotaxin (ATX) is a secreted glycoprotein widely present in biological ﬂuids, originally isolated from the
supernatant of melanoma cells as an autocrine motility stimulation factor. Its enzymatic product,
lysophosphatidic acid (LPA), is a phospholipid mediator that evokes growth-factor-like responses in almost
all cell types through G-protein coupled receptors. To assess the role of ATX and LPA signalling in
pathophysiology, a conditional knockout mouse was created. Ubiquitous, obligatory deletion resulted to
embryonic lethality most likely due to aberrant vascular branching morphogenesis and chorio-allantoic
fusion. Moreover, the observed phenotype was shown to be entirely depended on embryonic, but not
extraembryonic or maternal ATX expression. In addition, E9.5 ATX null mutants exhibited a failure of neural
tube closure, most likely independent of the circulatory failure, which correlated with decreased cell
proliferation and increased cell death. More importantly, neurite outgrowth in embryo explants was severely
compromised in mutant embryos but could be rescued upon the addition of LPA, thus conﬁrming a role for
ATX and LPA signalling in the development of the nervous system. Finally, expression proﬁling of mutant
embryos revealed attenuated embryonic expression of HIF-1a in the absence of ATX, suggesting a novel
effector pathway of ATX/LPA.Biomedical Sciences Research
6672, Athens, Greece. Fax:
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Autotaxin (ATX, ENPP2) is a secreted glycoprotein widely present
in biological ﬂuids, including blood, cancer ascites, synovial ﬂuid and
cerebrospinal ﬂuid (CBF), originally isolated from the supernatant of
melanoma cells as an autocrine motility stimulation factor (Stracke et
al., 1992). Increased ATX expression has been detected in a large
number of malignancies, including mammary, thyroid, hepatocellular
and renal cell carcinomas, non-small-cell lung cancer, as well as
glioblastoma and neuroblastoma (Umezu-Goto et al., 2004; van
Meeteren and Moolenaar, 2007).
ATX is encoded by a single gene on human chromosome
8 (mouse chromosome 15) whose transcription, regulated by diverse
transcription factors (Hoxa13, NFAT-1 and v-jun), results in threealternatively spliced isoforms (α, β and γ) (Giganti et al., 2008; van
Meeteren and Moolenaar, 2007). ATX is synthesized as a prepro-
enzyme, secreted into the extracellular space after the proteolytic
removal of its N-terminal signal peptide (Jansen et al., 2005). ATX is
a member of the ectonucleotide pyrophosphatase/phosphodiester-
ase family of ectoenzymes (E-NPP) that hydrolyze phosphodiester-
ase (PDE) bonds of various nucleotides and derivatives (Stefan et al.,
2005). More importantly, ATX has been identiﬁed as the long elusive
plasma lysophospholipase D (lysoPLD), an enzyme that mainly
catalyzes the conversion of lysophosphatidylcholine (LPC) to
lysophosphatidic acid (LPA) (Tokumura et al., 2002; Umezu-Goto
et al., 2002).
LPA is produced in various conditions both in cells and in biological
ﬂuids and is a major constituent of serum, tightly bound to albumin
and gelsolin (Aoki, 2004; van Meeteren and Moolenaar, 2007). LPA is
a phospholipid mediator that evokes growth-factor-like responses in
almost all cell types, including cell growth, survival, differentiation
and motility (Luquain et al., 2003; Mills and Moolenaar, 2003;
Moolenaar et al., 2004). The large variety of LPA effector functions is
attributed to at least six, G-protein coupled, LPA receptors with
overlapping speciﬁcities and wide spread distribution (Choi et al.,
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affect various pathological conditions and cellular pathways, thus
attracting increased diagnostic and pharmacological interest (Fuchs
and Schiller, 2009).
ATX expression is ﬁrst detected at the ﬂoor plate of the neural tube,
as well as in the choroid plexus of the embryonic brain (van Meeteren
andMoolenaar, 2007), which was shown to be an essential organizing
center for inducing dorsal neuron fates and sustaining neuron
function (Awatramani et al., 2003) and was identiﬁed as a possible
location of stem/progenitor cells (Li et al., 2002). In the post-natal
CNS, ATX is expressed in secretory epithelial cells, such as the choroid
plexus, ciliary, iris pigment, and retinal pigment epithelial cells,
whereas there is evidence for ATX expression in leptomeningeal cells
and cells of the CNS vasculature (vanMeeteren andMoolenaar, 2007).
ATX was found upregulated during oligodendrocyte maturation,
temporally correlated with the process of myelination (Dugas et al.,
2006; Fox et al., 2003; Fuss et al., 1997), while signiﬁcant ATX
expression was detected in the CBF of multiple sclerosis patients
(Hammack et al., 2004). Increased ATX expression was also detected
in activated astrocytes following brain lesion (Savaskan et al., 2007),
as well as in the frontal cortex of Alzheimer-type dementia patients
(Umemura et al., 2006).
High levels of LPA have been demonstrated in the brain, shown to
affect most neural cell types, impacting axonal and dendritic
morphology, neuronal apoptosis, neural precursor cell survival,
process retraction in oligodendrocyte precursors, hypertrophy of
astrocytes and microglial activation and migration (Fukushima, 2004;
Fukushima et al., 2002). Furthermore, LPA levels are increased during
pathological conditions of the brain, such as in response to injury,
cerebral ischemia, and following disruption of the blood-brain barrier
(Fukushima, 2004; Fukushima et al., 2002). In accordance, LPA
receptors are enriched in the CNS and their expression patterns
suggest their potential involvement in developmental process
including neurogenesis, neuronal migration, axon extension and
myelination (Ishii et al., 2004).
In the present study we report the creation of a novel conditional
(LoxP) knock out mouse for ATX (exons 1–2; C57BL/6 genetic
background). As previously reported (Koike et al., 2009; Tanaka et al.,
2006; van Meeteren et al., 2006), ubiquitous deletion of ATX resulted
to embryonic lethality most likely due to aberrant vascular branching
morphogenesis and chorio-allantoic fusion. Moreover, the observed
phenotype was shown to be entirely dependent on embryonic, but
not maternal or extraembryonic, ATX expression. In addition and
through the use of a neuronal reporter transgene, we have shown that
ATX null mutants exhibited failure of neural tube closure correlating
with decreased cell proliferation and increased cell death, while LPA
was shown to rescue growth and neurite outgrowth in embryonic
explants. Expression proﬁling of mutant embryos revealed a large
number of deregulated genes and pathways; among them the
expression of hypoxia-inducible factor 1-a (HIF-1a) was found




All mouse strains used were maintained on a C57BL/6 genetic
background at the animal facilities of the Biomedical Sciences
Research Institute “Alexander Fleming” under speciﬁc pathogen free
conditions, in compliance with the Declaration of Helsinki princi-
ples. Mice were housed at 20–22 °C, 55±5% humidity, and a 12 h
light-dark cycle; food and water was given ad libitum. All
experimentation was approved by an internal Institutional Review
Board, as well as by the Veterinary service and Fishery Department
of the local governmental prefecture. The generation of CMV-Cre,Sox2-Cre and Tie1-Cre transgenic mouse lines have been reported
previously (Gustafsson et al., 2001; Hayashi et al., 2002; Schwenk et
al., 1995).
Generation of an Enpp2 targeting vector
For the construction of an Enpp2 targeting vector (Fig. 1A), a
C57BL/6 BAC clone (RPCI-216A) encompassing the Enpp2 gene was
obtained and PCR primers with appropriate restriction sites at their
termini were designed for the ampliﬁcation of a 5-Kb 5′ ﬂanking
fragment (left homology arm, LA), a 1.2-Kb central fragment
(containing exons 1 and 2 of the Enpp2 gene, central homology
arm, CA) and a 4-Kb 3′ ﬂanking fragment (right homology arm, RA),
respectively. After PCR ampliﬁcation with a proofreading polymerase
(Pfu Turbo, Stratagene, CA, USA), each fragment was subcloned into
pBluescript KSM plasmid, using the restriction sites attached to the
termini of PCR primers. CA was excised (as a NotI–SalI fragment) from
pBluescript KSM and introduced in the pEasyFlox targeting vector,
followed by subcloning of RA (as a RhoI fragment) and LA (as NotI
fragment). Primer sequences (5′ to 3′) were as follows: LA-F: GCG
GCC GCG AGA TGT CAC ATA CTC TTT; LA-R: AGT ATG AGA AAC AGA
CA; CA-F: TCT AGA CAG AAG GGC TTT ATG CAG CT; CA-R: GTC GAC
TAA ATG TAT CGC CCT GCA CA; RA-F: CCC AAG GTG AGA ATA GGT TA;
RA-R: CTC GAG CGT ACA TTA TGC TCA GTG GC.
Following proofreading with sequencing of all restriction sites and
the entire CA (containing exons 1–2), the targeting construct was
linearized with SﬁI and electroporated into Bruce-4 (C57BL/6)
embryonic stem (ES) cells. After positive selection with neomycin,
southern blot analysis of EcoRV-digested DNA (Fig. 1B) from 192
drug-resistant clones with a 5′ ﬂanking external probe (P1), yielded
23 correctly targeted clones (12%). The integrity of the construct was
veriﬁed with southern blot analysis of BamHI-digested ES DNA with a
3′ external probe (Fig. 1A P2, data not shown).
Genomic DNA isolation and Southern blot
DNA was isolated by Proteinase K digestion (10 μg/ml, Roche
Diagnostics, Mannheim, Germany) of tail snips and ethanol precip-
itation. DNA samples (10 μg) were digested with EcoRV and
separated by agarose gel electrophoresis (0,8% in TAE buffer).
Following transfer of DNA into positively charged nylon transfer
membrane (Hybond-N+, Amersham Pharmacia Biotech Ltd., Little
Chalfont, Buckinghamshire, UK) hybridization with radiolabelled
probe P1 was performed at 65 °C in Hybuffer (7% SDS, 10% PEG, 1,5×
SSPE, 100 μg/ml salmon sperm).
PCR Genotyping of targeted ES cells and conditional Enpp2n/n mice
To be able to identify all Cre-mediated recombination events 5
primers were designed (A1, B1, C1, A2 and B2; Fig. 1A). Primer
sequences were as follows (5′ to 3′): A1: CGC ATT TGA CAG GAA TTC
TT; B1: ATT TGT CAC GTC CTG CAC GA; C1: ATC AAAATA CTGGGG CTG
CC; A2: CGA ATC TCT CCG ATC ACT AC; B2: TAC ACA ACA CAG CCG TCT
CA. Primer set A1/C1 yields a PCR product of 223 bp corresponding to
the wild type (WT) alleles. Primer set A1/B1 yields a PCR product of
456 bp corresponding to the ﬂoxed (neo) allele. Detection of the
recombined allele is achieved by primer set A1/B2 that yields a PCR
product of 422 bp. Primer set A2/B2 yields 552 and 459 bp products
for the ﬂoxed (neo) and wt alleles respectively. Use of primer set A2/
B2 conﬁrms the presence or absence of Loxp3 thus verifying that Cre-
mediated recombination resulted in the efﬁcient excision of exons 1–
2 that are ﬂanked by LoxP2–P3 (and not in the excision of sequences
ﬂanked by LoxP1–2).
All PCRs were performed with 50–100 ng DNA, 0.125–0.250 mM
dNTPs, 0.25–0.5 pmol of each primer, a custom made Taq DNA
polymerase and 1.5 mM MgCl2 for 1 cycle at 94 °C for 3 min, 25–30
Fig. 1. Generation and biochemical characterization of mutant Enpp2 mice. (A) Schematic representation of the Enpp2 locus, the targeting vector, and the mutated Enpp2 alleles.
Exons are indicated by ﬁlled boxes and LoxP sites by open triangles. Probes P1 and P2, and PCR primers A1, A2, B1, B2 and C1 are also depicted. B: BamHI sites; E: EcoRV sites. (B)
Southern blot analysis of targeted ES cell clones indicating (⁎) correctly targeted clones. Genomic DNA was digested with EcoRV and screened with a 5′ ﬂanking probe (P1). (C)
Genotyping of adult mice and E9.5 embryos with conditional Enpp2n (A1/B1/C1) or deleted Enpp2− (A1/B2/C1) alleles with PCR primers. (D) Plasma ATX levels as determined with
an ELISA assay (n=3–6). (E) ATX activity assay as detected through the hydrolysis of its ﬂuorogenic substrate FS-3 (n=4–5). (F) Plasma LPA levels as determined with LC/MS
(n=8–10). (G) Immunodetection of ATX in frozen sections of E9.5 embryos. Data in D–F are presented as bar charts of mean values±SD depicted by error bars. ⁎denotes statistical
signiﬁcance (pb0.05) as assessed with t-test.
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72 °C for 3 min.
Serum/plasma isolation
Blood was collected from mouse tail vein and incubated at 4 °C for
10 min. Serum was obtained by centrifugation at 6000 rpm for 8 min
and at 12000 rpm for 8 min at 4 °C and stored at−80 °C. For plasma
isolation, blood was collected in 50 mM EDTA, centrifuged at
12000 rpm for 8 min at 4 °C and stored in siliconized tubes at -80 °C.
ATX ELISA
To detect ATX in biological ﬂuids, a direct ELISA assay was
developed using the commercially available anti-phospholipase D
polyclonal antibody (Cat. No. 10005375, Cayman chemical, USA). The
bottom of a NUNC-IMMUNO 96 MicroWell Elisa plate was coated
overnight with 100 μl of 1:200 diluted serum in 0.05 M carbonate/
bicarbonate coating buffer, pH 9.5 (Cat. No. S7795/S7277, Sigma, Saint
Louis, MI, USA), washed three times with 0.05% Tween-20 (Cat. No.
P1379, Sigma, USA) in TBS and blocked with 0.1% Bovine Serum
Albumin (Cat. No. A7888, Sigma, USA) in 0.05% TBST for 1 h at RT. For
each ELISA assay, 100 μl of two-fold serial dilutions of recombinant
ATX protein ranging from 0.1 to 1.6 μg/ml were plated as standard
curve and treated as all samples. The plate was then incubated with
0.5 μg/ml detection antibody for 1 h and washed three times with
0.05% TBST. Autotaxin antigen was then detected with an anti-rabbit
HRP-labeled secondary antibody (Cat. No. 4010-05, SouthernBiotech,
USA) that was developed with TMB substrate (Cat. No. A7888, Sigma,
USA). Readings were obtained at 450 nm. All samples and standards
were assayed in triplicates.
ATX activity assay
Autotaxin activity in plasma of mice was determined using the
cleavage of the ATX-speciﬁc ﬂuorogenic substrate FS-3 (Echelon
Biosciences, UT, USA). Assays were conducted in a ﬁnal volume of
100 μl comprising 20 μl 5× assay buffer (700 mM NaCl, 25 mM KCl,
5 mM MgCl2 and 250 mM Tris, pH 8.0), 20 μl of FS-3 (ﬁnal
concentration 2.5 μM) and 60 μl of plasma (diluted 1:5 in 1× PBS).
Reactions were incubated at 37 °C in a Tecan Inﬁnite 200 microplate
reader (Tecan Trading AG, Switzerland) set to make ﬂuorescence
measurements every 5 min for 1 h. Autotaxin activity was quantitied
by measuring the rate of ﬂuorescence increase at 528 nm with
excitation at 485 nm.
LC/MS
Lipids were extracted as previously described (Xiao et al., 2001).
Mass spectrometry analyses were performed using API-4000 (Applied
Biosystems/MDS SCIEX). Samples (10 μl) were loaded through a LC
system (Agilent 1100) with an auto sampler. The mobile phase was
MeOH/water/NH4OH (90:10:0.1, v/v/v). A TARGA C18 5 μm,
20×2.1 mm TR-0221-C185 (Higgins Analytical, Southborough, MA
USA) HPLC column was used for the separation of different lipids and
for the detection of LPA and S1P. The HPLC conditions were 12 min/
sample using the following three-phase ﬂow rate scheme: 1)
increasing ﬂow rate from 0.2 to 0.5 ml/min for the ﬁrst 5 min; 2)
constant ﬂow rate of 0.5 ml/min for 5 min and 3) decreasing ﬂow rate
from 0.5 to 0.2ml/min for 2min. Standard curves were established for
quantitative analysis as previously described (Xiao et al., 2001).
Embryo histopathology
For histopathology, embryos were ﬁxed in 10% formalin O/N at
4 °C. 4 μM thick embryo sections were stained with Hematoxylin/Eosin and visualized under a Nikon ECLIPSE E800 microscope (Nikon
Corp., Shinagawa-ku, Tokyo, Japan).
For immunohistochemistry, embryos were ﬁxed in 4% parafor-
maldehyde for 2 h at RT. After three washes in PBS (15 min), embryos
were incubated in 30% sucrose for 12 h at 4 °C followed by embedding
in OCT (BDH, Poole, UK) and storage at −70 °C. 7-μm thick serial
embryo cryosections were immunostained with primary antibodies
against Shh, AP2a, Pax3, Islet1, Pax6 (1:100; Developmental Studies
hybridoma bank, University of Iowa, Iowa, USA) Sox2 (Chemicon/
Millipore, Billerica, MA, USA) and Sox10 (Abcam Inc, Cambridge, MA,
USA). Mitotic cells were labeled with anti-phospho histone H3
antibody (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
O/N at 4 °C. Neurite outgrowth was monitored with immunostaining
of TuJ1, a neuronal differentiationmarker (1:500, Covance, Richmond,
CA, USA). Following incubation with the appropriate secondary
antibodies conjugated to Alexa ﬂuorophore 488 or 555 (1:500,
Molecular Probes/Invitrogen, Carlsbad, CA, USA) for 1 h at RT,
sections were mounted and observed under a ﬂuorescent microscope
(Nikon Corp., Shinagawa-ku, Tokyo, Japan).
For X-Gal staining, embryos were ﬁxed in 0.2% glutaraldehyde, 2%
formaldehyde at 4 °C for 10min, followed by threewashes in Lo buffer
(100mM PB, 2mMMgCl2, 5 mMEGTA) for 5min each. Embryoswere
then stained in X-gal staining solution (100 mM PB, 2 mM MgCl2,
5 mM EGTA, 0.01% deoxycolic acid, 0.02% IGEPAL, 500 mM potassium
ferricyanide, 500 mM potassium ferrocyanide, 1 mg/ml X-gal) at
37 °C until the desired color intensity was reached (several hours to
O/N). After staining, embryoswerewashed three times for 5min each
in PBS buffer, reﬁxed with 4% paraformaldehyde at 4 °C for 30 min to
O/N and then dehydrated through a methanol gradient mounted and
observed under light microscope.
For the TUNEL assay, 5-μm thick OCT-embedded embryo cryosec-
tions were used for in situ labelling of apoptotic cells (TUNEL assay)
using the terminal deoxynucleotidyl transferase enzyme (TdT) (In
situ cell death detection kit (AP), Roche Diagnostics GmbH, Man-
nheim, Germany). Sections were mounted on coverslips and
evaluated by light microscopy. Negative (omission of TdT) and
positive (sections treated with DNaseI) controls were included in all
analyses.
For the in situ hybridization, embryos were ﬁxed in 4% parafor-
maldehyde in 0.1 M phosphate buffer at 4 °C for 2 h. They were then
dehydrated through amethanol gradient and stored in 100%methanol
at−20 °C. For hybridization Patch1 cDNA was used in vector pBS KS
which allowed the generation of antisense probe by in vitro
transcription using a linearized vector and the T7-RNA-polymerase.
Embryo explants culture and embryo histopathology
E8.5 embryos were dissected in DMEM F:12 supplemented with
2 mM Glutamine, penicillin and streptomycin (all from Gibco-Life
Technologies-Invitrogen, Carlsbad, CA, USA). The somitic part of the
trunk was dissected and placed onmatrigel support in the presence of
DMEM F:12 medium supplemented with 10% FCS, 15% chicken
embryo extract (SLI, Bolney, West Sussex, UK), 2 mM glutamine,
20 ng/ml bFGF and Penicillin-Streptomycin (10 U/ml–100 μg/ml;
Gibco-Life Technologies-Invitrogen). Explants were cultured at 37 °C,
5% CO2 for 48 h. For the rescue experiments, media were supple-
mented with 10 μM LPA (Avanti, polar lipids, Alabaster, AL, USA).
RNA extraction, microarray hybridizations and data analysis
RNAs from E9.5 embryos were puriﬁed with Trizol (Invitrogen Ltd,
Paisley, PA4 9RF, UK), followed by a single passage from RNeasy
columns (QIAGEN GmbH, Hilden, Germany) according to manufac-
turers’ instructions. RNA integrity was assessed on Agilent's Bionaly-
zer and 0.2 μg of total RNA was used to generate biotinylated
complementary RNA (cRNA), according to the “Two-Cycle Target
Table 1
Genotypes of progeny from Enpp2+/− heterozygous intercrosses.
Development
stage
% Genotypea No of
progeny
Enpp2+/+ Enpp2+/− Enpp2−/−
E8.5 23 (25) 44 (50) 33 (25) 54
E9.5 27 (25) 45 (50) 28 (25) 74
E10.5 26 (25) 58 (50) 16 (25) 20
PO 35 (25) 65 (50) 0 (25) 100
PO: post natal day 0
aobserved (expected).
Table 2
Genotypes of progeny from cell speciﬁc Enpp2 deletion.
% Genotype a No of
progeny
Enpp2 n/+ Enpp2 n/n
Cre Transgene +/− −/− +/− −/−
♀ Sox2Cre 26.5 (25) 55.1 (25) 0 (25) 18.4 (25) 49
♂ Sox2Cre 11.2 (25) 62.9 (25) 0 (25) 25.9 (25) 27
Tie1Cre 28.1 (25) 31.7 (25) 19.3 (25) 19.12 (25) 114
a observed (expected).
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ual; Affymetrix, Santa Clara, CA 95051, USA; Revision 510). Fragmen-
ted cRNA samples were then hybridized onto the Affymetrix MOE430
2.0 GeneChip expression arrays (following testing on Affymetrix Test3
arrays). Hybridization quality controls were performed using the
Affymetrix GeneChip Operating System (GCOS) and data quality
control analysis was performed in R-Bioconductor v2.3.1 and in Partek
Genomics suite software ver6.3 (Partek Incorporated, St. Louis, MO,
USA). Following quality controls, gcRMA quantile normalization was
conducted on the data using R-Bioconductor v2.3.1. ANOVA statistics
was performed on Partek Genomics suite. The complete, MIAME-
compliant (Brazma et al., 2001) data set (both raw and normalized) is
publicly available (#E-MEXP-1881) at ArrayExpress (Parkinson et al.,
2007).
Results
Generation of a conditional knockout Enpp2 mouse allele
To assess the role of ATX in pathophysiology through the
inactivation of its expression in a cell/tissue speciﬁc manner, we
created an ATX conditional knockout allele. LoxP sites were
genetically engineered to ﬂank the ﬁrst two exons of the Enpp2
gene (Fig. 1A) and thus completely abolish any expression from the
Enpp2 locus upon cell/tissue speciﬁc Cre expression and subsequent
Cre-mediated recombination. A neomycin ﬂoxed cassette was also
inserted immediately upstream of ﬂoxed exons to be used as a
positive selection marker of targeted embryonic stem cells (ES;
C57BL/6). ES clones carrying the genetically modiﬁed Enpp2 allele
(Enpp2n; Fig. 1B) were injected into C57BL/6 blastocysts, which were
then implanted into foster mothers. Chimeric offspring were mated to
C57BL/6 mice and the F1 generation was screened for germ line
transmission of the targeted allele by southern blot (data not shown)
and PCR analysis (Fig. 1C). Enpp2n/n mice (obtainedwith intercrossing
of heterozygous Enpp2n/+ mice) were found correctly targeted and
exhibited no phenotypic or breeding anomalies.
Ubiquitous, germ line ablation of Enpp2 results to embryonic lethality
To induce ubiquitous, germ line inactivation of the Enpp2 gene,
Enpp2n/n mice were crossed with a transgenic mouse strain expres-
sing the Cre recombinase driven by the CMV promoter (Schwenk et
al., 1995). Offspring heterozygous null mutant mice (Enpp2+/−) were
found properly recombined (Fig. 1C) and exhibited no phenotypic or
breeding anomalies. However, recombinant Enpp2+/−mice produced
almost 50% less ATX in their serum, as detected with ELISA (Fig. 1D).
Concomitantly, ATX activity, as detected through the hydrolysis of its
ﬂuorogenic substrate FS-3 (Ferguson et al., 2006), was also found 50%
decreased (Fig. 1E). In turn, LPA levels in their plasmawere also found
decreased by 50% (Fig. 1F). No differences in serum LPA levels were
detected (Enpp2+/+ 1.9 μΜ±0.1; Enpp2−/− 2.0 μΜ±0.1; as assayed
with a radioenzymatic assay (Saulnier-Blache et al., 2000)), due to
platelet activation and subsequent LPA release as previously reported
(van Meeteren and Moolenaar, 2007; van Meeteren et al., 2006).
Intercrossing of heterozygous Enpp2+/− mice produced no
homozygous Enpp2−/− offspring among 100 newborn mice (P0;
Table 1), indicating that genetic deletion of ATX results to embryonic
lethality (Tanaka et al., 2006; van Meeteren et al., 2006). To identify
the lethal embryonic stage, embryos from heterozygous Enpp2+/−
intercrosses were isolated at different embryonic days post coitum (E)
and PCR genotyped from their respective yolk sacs (Fig. 1C). Normal
mendelian ratios (Table 1) were observed at E8.5 and E9.5 (albeit with
severe malformations as described below), while at E10.5 a large
number of knockout embryos had been resorbed while the remaining
ones appeared necrotic (Tanaka et al., 2006; van Meeteren et al.,
2006). Therefore Enpp2−/− mutant embryos die soon after E9.5, thedevelopmental point that ATX expression is ﬁrst detected at the ﬂoor
plate of the neural tube (Bachner et al., 1999).
To examine if the observed embryonic lethality could be attributed
to the reducedmaternal levels of ATX and LPA (Enpp2+/−; Figs. 1D–F),
embryos from Enpp2+/− intercrosses were transferred to wild type
surrogate mothers. No differences were observed in embryonic
lethality or embryonic phenotypes (data not shown), indicating that
the observed embryonic phenotype was not due to the reduced
maternal levels of ATX and LPA.
Moreover and in order to exclude possible extraembryonic effects
in the absence of ATX, we have utilized a transgenic mouse strain
expressing the Cre recombinase driven by the Sox2 promoter. Paternal
Sox2Cre transgene transmission induces recombination in all epiblast
cells but little or no activity in extraembryonic cell types and tissues,
such as the yolk sac (Hayashi et al., 2002; Vincent and Robertson,
2003). On the contrary, when the Sox2Cre is contributed maternally
recombination occurs in both embryonic and extraembryonic tissues
(Hayashi et al., 2002; Vincent and Robertson, 2003). As it can be seen
at Table 2, no Enpp2n/n Sox2Cre+/− mice could be detected among
offspring, irrespectively of the Sox2Cre transmission. Moreover, Sox2-
driven, Cre-mediated ATX ablation resulted in identical embryonic
lethal phenotypes with the CMV-driven ones (data not shown).
Therefore embryonic only ATX deletion (with parental Sox2Cre
transgene transmission) is, most likely, sufﬁcient for the observed
phenotype and lethality.
Circulatory failure in Enpp2−/− embryos
At E8.5, Enpp2−/− embryos exhibited normal growth (and somitic
pairs) and gross patterning of embryonic structures (Figs. 2A, B) (van
Meeteren et al., 2006). However and in 50% of mutant embryos
analyzed, there was abnormal development of the allantois which
appeared swollen and failed to fuse to the chorion (Fig. 2C) (Tanaka et
al., 2006; van Meeteren et al., 2006). Of note, all mutant embryos
appeared phenotypically similar irrespective of their allantoic fusion.
At E9.5, Enpp2−/− embryos (that expressed no ATX protein; Fig. 1G)
failed to initiate axial turning and exhibited retarded overall growth
(and reduced somitic pairs) (Figs. 2A and 3A) (Tanaka et al., 2006;
van Meeteren et al., 2006). Enpp2−/− yolk sacs presented with
aberrant vascular branching morphogenesis (Fig. 2D), despite
adequate development of vessels (which furthermore appeared
enlarged) (van Meeteren et al., 2006). Erythrocytes appeared normal
but trophoblast giant cells and chorionic plate cells showed signs of
Fig. 2. Genetic, ubiquitous deletion of ATX results in retarded growth, aberrant vascular branching morphogenesis, defective chorio-allantoic fusion and neural tube defects. (A)
Dark-ﬁeld microscopy of the indicated embryos showing retarded growth and axial turning defects in the absence of ATX. (B) Haematoxylin and eosin staining of the indicated
parafﬁn-embedded embryos showing neural tube defects in the absence of ATX. (C) Dark-ﬁeld microscopy of the indicated embryos showing abnormal development of the allantois
in the absence of ATX. (D) Defective yolk sac vascular branching morphogenesis in the absence of ATX as shown with dark-ﬁeld microscopy.
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Fig. 3. Defective chorio-allantoic fusion in the absence of ATX despite normal levels of VEGF and proper (gross) development of endothelial and smooth muscle cells. (A)
Haematoxylin and eosin staining of the indicated parafﬁn-embedded placentas at E9.5. (B–D) Immunostaining of the indicated embryo sections for VEGF, VEGFR2 and SMA
respectively.
457S. Fotopoulou et al. / Developmental Biology 339 (2010) 451–464degeneration and the allantoic blood vessels failed to spread into the
decidual zone (Fig. 3A) (Tanaka et al., 2006). Enlarged vessels were
also observed in the cephalic region of Enpp2−/− embryos (Fig. 2B);
the heart could still beat at E9.5 Enpp2−/− embryos (albeit non-rhythmically; videos not shown). The apparent circulatory failure of
Enpp2−/− embryos was not due to reduced levels of VEGF or VEGFR2
(as detected with immunostaining; Figs. 3B and C respectively) or
any apparent endothelial or smooth muscle differentiation defect as
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et al., 2006)) and smooth muscle actin/SMA staining (Fig. 3D).
Moreover, ATX deletion speciﬁcally in the endothelium (driven by the
Tie1 promoter) (Gustafsson et al., 2001) did not lead to embryonic
lethality (Table 2) or any developmental defects (data not shown).
ATX and LPA signaling are necessary for the development of the nervous
system
Themost striking developmental defect of E9.5 Enpp2−/− embryos
was the failure of neural tube closure (Fig. 2B). The development of
the neural tube in Enpp2−/−mice was further monitored with the use
of the reporter gene Sox1bgeo (that expresses speciﬁcally in the
neural system and is detected by lacZ staining) (Ekonomou et al.,
2005). Phenotypic analysis of E9.5 Enpp2−/−/Sox1bgeo+/− embryos
conﬁrmed the failure of neural tube closure and the asymmetric
headfolds in the absence of ATX and indicated a kinky neural tube
along the anterior–posterior axis (Figs. 4A and B).
Embryonic growth and development (including neural tube
closure and neuronal development) are dependent on cell migration,
regional differences in mitotic rate, and speciﬁc sites and rates of
programmed cell death. As LPA has been reported tomodulate each of
these processes in various cell types in vitro (van Meeteren and
Moolenaar, 2007), we next analyzed proliferation (through staining of
the mitotic marker phospho histone H3; PH3) and cell death (TUNEL
assay) at E9.5 Enpp2−/− embryos and wt littermates. In the wt
embryos, mitotic cells could easily be distinguished in the neural tube
region, almost completely absent at the Enpp2−/− embryos (Figs. 4C,
E). Reversely, very few scattered TUNEL+ cells could be detected in
the wt embryos, while massive cell death could be observed at the
neural tube in the absence of ATX/LPA (Figs. 4D, F).
To identify if the failure of neural tube development could be due
to aberrant dorsal–ventral (D–V) patterning, we next examined the
sonic hedgehog (Shh) signalling pathway, themaster regulator of D–V
patterning and neural plate bending, also implicated in neural cell
proliferation and survival (Cohen, 2003; Ho and Scott, 2002).
However no differences in the expression of Shh (and its receptor
Ptch1) were observed at Enpp2−/− E9.5 embryos (Fig. 5). Similarly no
signiﬁcant changeswere observed in the expression pattern of various
bona ﬁde D–V patterning genes (Sox2, Sox10, Ap2a, Pax3, Pax6 and
Islet1) (Fig. 5). Therefore, aberrant neural tube development in the
absence of ATX/LPA is not due to deregulated Shh signalling and D–V
patterning, but most likely due to the absence of LPA signalling.
To further explore a role for ATX/LPA in neuronal differentiation
and growth, we isolated and cultured the somitic part of the embryo
trunk from E8.5 embryos (6–8 somites) as described in Materials and
methods. After 2 days in culture, Enpp2−/− explants grew to only half
the size of their wt littermates (Fig. 6), in analogy with embryo size in
utero. Moreover, neurite outgrowth, as detected with TUJ1 staining,
was found severely compromised in the absence of ATX (Fig. 6). Both
embryo explant size and neurite outgrowthwere restored to wt levels
upon the addition of LPA, strongly suggesting that the role of ATX in
the development of the nervous system is mainly mediated by its
enzymatic product, LPA.
Expression proﬁling of Enpp2−/− embryos
To explore systematically changes in gene expression in the
absence of ATX, total RNA from E9.5 Enpp2−/− embryos and wt
littermates were hybridized (in triplicates) to Affymetrix DNAFig. 4. Failure of neural tube closure in the absence of ATX/LPA correlates with decreased pro
the expression of the neuronal marker Sox1bgeo+/− detected with LacZ staining in whole em
the mitotic marker phospho histone H3. (D) Detection of cell death with TUNEL assay. (
(Telencephalon, TE; Diencephalon, DE) of three embryos from each indicated genotype. Res
statistical signiﬁcance (pb0.05) as assessed with t-test.oligonucleotide microarrays interrogating the expression of 45,101
probesets corresponding to over 39,000 genes. Following quality
controls, normalization and statistical analysis, 499 differentially
expressed genes (DEGs) were identiﬁed with statistical signiﬁcant
changes in their expression in the absence of ATX/LPA (pb0.05; False
Discovery Rate (FDR)b0.05; Fold Change (FC)N2; Supplemental
Table S1).
Moreover, to infer deregulated biological processes and molecular
functions from the gene expression data, as these are encoded in the
Gene Ontology (GO) (Ashburner et al., 2000) terms assigned to each
known gene, we analyzed GO term frequencies in the selected 499
DEGs list. The statistical signiﬁcant (pb0.05) deregulated processes
and functions (Supplemental Table S2) include a number of well
expected, basal perturbations (in transcription, translation and
different enzymatic activities) and a number of perturbations
essentially describing the apparent phenotype of Enpp2−/− embryos
(cell cycle, cell differentiation, patterning of blood vessels, placental
development, neurogenesis, muscle contraction).
ATX and LPA are necessary for embryonic HIF-1a expression
Remarkably, among the most statistical signiﬁcant and differen-
tially expressed genes in the absence of ATX/LPA (Supplemental Table
S1), was Hif-1a, a subunit of the transcription factor HIF, the key
mediator of cellular responses to hypoxia (Semenza, 2007; Weide-
mann and Johnson, 2008). To validate the results, transverse sections
from Enpp2−/− embryos and wt littermates were immunostained for
HIF-1a. In wt embryos HIF-1a expressionwas localized at themarginal
layers of the neural tube and cephalic and intersomitic mesenchyme
(Fig. 7A), as previously described (Lee et al., 2001). No HIF-1a could be
detected at the mutant embryos (Fig. 7A), while no major differences
were observed in the expression pattern of HIF-2a (data not shown).
The lack of HIF-1a expression in the absence of ATX/LPA was
correlated with the absence of Akt (Akt1/2/3 Fig. 7B), a positive
regulator of HIF-1 (Bardos and Ashcroft, 2005) that has been
suggested to mediate LPA-induced cell migration (Kim et al., 2008).
Given the circulatory abnormalities of the mutant mice and in
order to examine if HIF-1a expression could reﬂect possible
differences in O2 tension, wt and Enpp2−/− E9.5 embryos were
double-immuno-labeled for HIF-1a and for the hypoxia marker
pimonidazole (Lee et al., 2001). As previously described (Lee et al.,
2001), in wt E9.5 embryos HIF-1a expression and hypoxic regions
were spatiotemporally colocalized (Fig. 7C). No major differences in
the hypoxic pattern were observed at Enpp2−/− embryos that albeit
completely lacked HIF-1a expression (Fig. 7C). Moreover and as the
absence of embryonic HIF-1a expression has been previously
correlated with mesenchymal cell death (Kotch et al., 1999), also
observed in the absence of ATX/LPA (Fig. 4C), wt and Enpp2−/− E9.5
embryos were double-immuno-labeled for HIF-1a and TUNEL+ cells.
As shown in Fig. 7C, cell death was observed in regions of Enpp2−/−
embryos that should have been expressing HIF-1a. More importantly,
HIF-1a immunostaining of somatic trunk explants sections indicated
that LPA was able not only to restore embryo size and neurite
outgrowth (Fig. 6) but both Akt and HIF-1a expression in ATX null
explants (Figs. 7B, C).
Discussion
As shown in this report, genetic deletion of ATX (through
conditional ﬂoxing of exons 1–2 and ubiquitous cre mediatedliferation and increased cell death. (A, B) Monitoring neural tube development through
bryos (A) or the corresponding sections (B). (C) Detection of proliferating cells through
E, F) Quantiﬁcation of proliferating (C) and dying (D) cells at two different regions
ults are presented as bar charts of mean values±SD depicted by error bars. ⁎ denotes
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Fig. 6. LPA stimulates embryo growth and rescues neurite outgrowth defect in the absence of ATX. wt andmutant embryo explants were cultured in vitro for 2 days in the presence or
absence of LPA and immunostained for TUJ1 to detect neurite outgrowth.
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E9.5 (Table 1). Analysis of the lethal embryonic phenotype in the
absence of ATX revealed retarded growth (Figs. 2A, B), severe
circulatory problems (Figs. 2C, D, 3A) and neural tube defects (Figs.
2B and 4A, B). Identical results were obtained in two previous efforts,
despite deletion of different exons, conditional or straight genetic
targeting and different genetic backgrounds (Koike et al., 2009;
Tanaka et al., 2006; van Meeteren et al., 2006). Similar embryonic
lethality was also obtained with a targeted point mutation at the
catalytic center of ATX (Ferry et al., 2007), which completely blocks
ATX's lysoPLD and PDE activities (van Meeteren and Moolenaar,
2007). Moreover and as shown here, the observed embryonic
phenotype was found completely independent of maternal or
extraembryonic levels of ATX. Therefore, ATX expression at the
developing embryo and ATX-mediated LPA production and subse-
quent G-protein coupled receptor (GPCR) signalling are essential for
vascular branching morphogenesis and chorio-allantoic fusion, which
seem to be the primary causes of embryonic death in the absence of
ATX. However, genetic deletion of ATX speciﬁcally from endothelial
cells did not produce any appreciable defect, thus excluding an
autocrine role for ATX in endothelial differentiation.
Similar defects in the vascular system as the ones observed at the
Enpp2−/− embryos have been also reported for Gα13−/− embryos
(Offermanns et al., 1997). Gα13 is a ubiquitously expressed subunit of
heterotrimeric G-protein complexes that act as molecular switches in
signal transduction pathways mediated by GPCRs (Oldham and Hamm,
2008), such as the LPA ones (Moolenaar et al., 2004). Remarkably,
Gα13 was discovered severely downregulated in Enpp2−/− embryos
(Supplemental Table S1), suggesting that the vascular defects in the
absence of ATX/LPA were possibly due to the lack of Gα13-mediated
signal transduction.
As Gα13−/− embryos exhibited no defect in neural tube
development, it seems that the neural tube defects observed at the
Enpp2−/− embryos are independent of the circulatory failure. In
accordance, ATX is ﬁrst expressed at the ﬂoor plate of the neural tube
at E9.5 (Fig. 1G) (Bachner et al., 1999), following the expression (E8.5)
of most LPA receptors at neural headfolds, forebrain and hindbrain
(Ohuchi et al., 2008). As shown here, ATX expression was found
necessary for proper neural tube development and closure (Figs. 4A,
B), correlating with decreased proliferation and increased apoptosis
(Figs. 4C, D), consistent with (most of) the responses of neural cell
lineages to LPA in vitro (Fukushima, 2004; Fukushima et al., 2002;
Ishii et al., 2004). More importantly, LPA could restore size and neurite
outgrowth in ATX deﬁcient embryo explants (at 10 μΜ—Fig. 6, as well
as with 5 mM—data not shown) establishing a role for LPA in neuralFig. 5. Dorsal–ventral patterning is normal in Enpp2−/−mutant embryos. (A–D) Immunosta
D–V patterning genes. (E) In-situ hybridization for the Shh receptor Ptch1.development. Of note, rescue experiments were performed in the
presence of bovine serumwhere LPA is present in high concentrations
(Aoki, 2004; Tigyi and Miledi, 1992) but is most likely inactivated
possibly due to binding to abundant albumin and/or gelsolin (Aoki,
2004; Tigyi and Miledi, 1992; Xu et al., 2009).
Neural tube defects (NTDs), similar the ones observed in Enpp2−/−
embryos, are found in a group of severe human congenital abnormal-
ities resulting from the failure of neurulation (De Marco et al., 2006).
The process of neurulation requires mechanisms including the planar
cell polarity pathway for the initiation of neural tube closure, relatively
unexplored in vertebrates (Wang and Nathans, 2007), and the sonic
hedgehog (Shh) signalling pathway, which regulates dorsal ventral
(D–V) patterning and neural plate bending (Cohen, 2003; Ho and
Scott, 2002). Shh is ﬁrst expressed in the notochord and the ﬂoor plate
of the neural tube, in close proximity with the site of ATX's ﬁrst
expression. However no differences in the expression of Shh, its
receptor Ptc1 and various bona ﬁde D–V patterning genes were
observed at Enpp2−/− E9.5 embryos (Fig. 5). Therefore, neural defects
were not due to aberrant D–V patterning in the absence of ATX/LPA
but most likely due to the absence of the LPA-mediated proliferation
and cell death inhibition. Moreover and as well known, embryonic
development and organogenesis are highly dependent on coordinated
migration of different lineages over short and long distances
throughout the body, while a large number of null mutants leading
to embryonic lethality havedirect effects on cytoskeletal dynamics and
cell migration (Kurosaka and Kashina, 2008). Early embryonic
migration in particular is dominated by cells of the neural crest
lineage that are classiﬁed into several types based on their origin and
destination (Tucker, 2004). Abnormal neural crest cell (NCC) migra-
tion in n-coﬁlin (Cﬂ1; an actin binding protein regulating cell
migration (Bellenchi et al., 2007)) null mutants was correlated with
abnormal neural tube morphogenesis and embryonic lethality
(Gurniak et al., 2005). As LPA has been reported to modulate coﬁlin
activity (Meberg et al., 1998) which has been implicated in regulating
migration of various cells (Moolenaar et al., 2004), and since absence
of ATX leads to decreased steady-state levels of coﬁlin phosphorylation
and actin polymerization (Koike et al., 2009), it seems very likely that
the absence of ATX/LPA would affect not only proliferation and
apoptosis in the developing neural system but neural crest cell
migration as well, affecting the development of various organs
(including heart and vessels).
Almost 200 mouse mutants with neural tube closure defects have
been reported, whose functions cluster in pathways of actin function,
apoptosis and chromatin methylation and structure (Harris and
Juriloff, 2007). Among them, only one was discovered deregulated inining of parafﬁn-embedded E9.5 embryo (anterior) sections for the indicated bona ﬁde
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463S. Fotopoulou et al. / Developmental Biology 339 (2010) 451–464the absence of ATX/LPA with expression proﬁling: Hif-1a (with the
highest negative fold change and among the most statistically
signiﬁcant). Embryonic HIF-1a expression was found severely compro-
mised in the absence of ATX/LPA, correlating with increased cell death
and diminished proliferation at the neural tube, independent of hypoxia
levels (Fig. 7). More importantly, LPA was shown to be able to restore
HIF-1a expression in ATX null embryonic explants ex vivo (Fig. 7E), as
well as embryo size and neurite outgrowth (Fig. 6). Hif-1a−/− mouse
mutants exhibit a very similar phenotype to Enpp2−/− embryos (unlike
LPA receptors null mutants (Choi et al., 2008)): developmental arrest
and lethality by E11, neural tube defects, aberrant yolk sac vascular
branching morphogenesis, marked cell death within the cephalic
mesenchyme, even enlarged vessels in the cephalic region (Iyer et al.,
1998; Ryan et al., 1998). Moreover, defective vascularization of Hif-1a
null mutants was not associated with VEGF deﬁciency (as in the case of
ATX null embryos) but with mesenchymal cell death (Kotch et al.,
1999). Although oxygen tension plays a major role in HIF-1a
stabilization and activation, several growth factors, cytokines and
oncogenes have been shown to induce HIF-1a expression under
normoxia, most likely through the PI3K/Akt and MAPK signalling
pathways (Bardos and Ashcroft, 2005; Semenza, 2007;Weidemann and
Johnson, 2008). Moreover, while Hif-1a activity is usually regulated at
the protein level, basal NF-κB activity (that interestingly is known to be
induced by LPA (Klemm et al., 2007)) is required for the expression of
enough mRNA at all times to result in the rapid accumulation of HIF-1a
protein (Rius et al., 2008), which occurs predominantly under hypoxia
(which nevertheless also induces mRNA expression (Belaiba et al.,
2007)). Unpublished results from our lab indicate that TNF, the major
pro-inﬂammatory cytokine, is able to induceHif-1amRNAexpression in
primary synovial ﬁbroblasts, while LPA can induce HIF-1a expression in
a smooth muscle cell line both at the mRNA and protein level (E.
Paraskeva and G. Simos personal communication). A few reports have
previously implicated LPA in hypoxia-dependent HIF-1a-mediated
responses in vitro (Kim et al., 2006; Lee et al., 2006; Park et al., 2007;
Sako et al., 2006). As shown here, ATX/LPA stimulate embryonic HIF-1a
expression (most likely through PI3K/Akt signalling and/or NF-κB)
independent of hypoxia levels, correlating with aberrant neural
development. Conditional deletion of ATX in neuronal lineages would
benecessary to further explore the suggested interrelationship between
ATX/LPA, HIF-1a and the development of the nervous system.
Additional experiments are also needed to establish if LPA can also
stimulate HIF-1a expression in adult tissues and thus contribute directly
or indirectly to various pathophysiological conditions including cancer,
where HIF-1a is a major therapeutic target (Semenza, 2003).Acknowledgments
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